|
|
|
News Release
For Immediate
Release (11/06/08)
Bernstein & Associates, Architects is pleased to announce the
publication of a new article about recent trends in pharmacy
design, including the design of pharmaceutical compounding
suites.
The article includes discussion of the design and construction
implications of the 2008 version of USP 797.
It also features details of the new pharmacy and pharmaceutical
compounding suite designed by the Bernstein & Associates,
Architects, for the Roswell Park Cancer Institute in Buffalo,
NY.
Entitled "Clean Spaces: A Look at the Revised and Reissued USP
797 Pharmacy Design Regulation", it was written by the firms
principal --- William N. Bernstein, AIA --- and was published in
the October issue of Health Facilities Management.
About the Firm:
Bernstein & Associates, Architects has specialized in healthcare
and lab design --- including the design of pharmacies and
pharmaceutical compounding suites --- since the firm’s founding
in 1990. The firm's pharmaceutical design expertise includes the
architecture, engineering and construction of USP 797-compliant
pharmacies. The firm's principal, William N. Bernstein, AIA, has
written extensively on pharmacy design and construction. Over
the past five years, Bernstein & Associates, Architects has
designed twenty USP 797-compliant pharmacies and pharmaceutical
compounding suites, a number of which have been featured in
architectural and healthcare publications.
For Further Information:
William N.
Bernstein, AIA
Principal - Bernstein & Associates, Architects - PLLC
59 West 19th Street - 6A New York, NY 10011
Office: 212.463.8200 - Fax: 212.463.9898
Email:
info@bernarch.com
www.bernarch.com
|
